Impulse Talks
Dr. Karl Nägler
Managing Partner, Wellington Partners
Topic:
Drug therapy, state 2043
Heimo Adamski
CEO 4GENE GmbH
Topic:
Improved molecules that change the world
Platform technology for “Improved Molecules” , in the fields of cosmetics, pharmaceuticals and industrial safety.
Dr. Daniel Reichart
Postdoctoral Fellow Department of Genetic Harvard Medical School und XTransplant Consultant
Topic:
Next generation diagnostics and therapeutics in cardiovascular medicine
Dr. Mathias Falcenberg
Executive Director, Head Search & Evaluation, Merck Healthcare
Welcome & Moderation
Dr. Peter Hanns Zobel,
Managing Director of the IZB
Anouschka Horn
Bavarian Television
